Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6844 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 |
filingDate |
2015-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2018-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2018500046-A |
titleOfInvention |
Method for predicting sensitivity to vascular endothelial growth factor receptor inhibitor |
abstract |
The present invention relates to a method for predicting susceptibility to treatment using a vascular endothelial growth factor receptor (VEGFR) inhibitor using a biomarker. According to the present invention, an effective means for anticancer treatment for liver cancer and anticancer therapy by predicting the effect on treatment using a vascular endothelial growth factor receptor (VEGFR) inhibitor of a liver cancer patient Can be selected to enhance the therapeutic effect and minimize the side effects of liver cancer treatment. [Selection] Figure 3 |
priorityDate |
2014-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |